Effect of azithromycin on incidence of acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease: a secondary analysis of the BREATHE trial

BACKGROUND: In the BREATHE trial weekly azithromycin decreased the rate of acute respiratory exacerbations (AREs) compared to placebo among children and adolescents with HIV-associated chronic lung disease (CLD) taking antiretroviral therapy (ART). The aim of this analysis was to identify risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Amy, McHugh, Grace, Simms, Victoria, Semphere, Robina, Ngwira, Lucky G, Bandason, Tsitsi, Mujuru, Hilda, Odland, Jon O, Ferrand, Rashida A, Rehman, Andrea M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599092/
https://www.ncbi.nlm.nih.gov/pubmed/34820609
http://dx.doi.org/10.1016/j.eclinm.2021.101195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599092/
https://www.ncbi.nlm.nih.gov/pubmed/34820609
http://dx.doi.org/10.1016/j.eclinm.2021.101195

Ejemplares similares